Related references
Note: Only part of the references are listed.Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions
Tal Sella et al.
JCO ONCOLOGY PRACTICE (2022)
Prevalence of prediabetes and diabetes vary by ethnicity among US Asian adults at healthy weight, overweight, and obesity ranges: an electronic health record study
William S. Vicks et al.
BMC PUBLIC HEALTH (2022)
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2021)
Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis
Ramy R. Saleh et al.
CANCER TREATMENT REVIEWS (2021)
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies
Samuel G. Smith et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Ethnic group differences in obesity in Asian Americans in California, 2013-2014
Shaoqing Gong et al.
BMC PUBLIC HEALTH (2021)
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
Lucia Del Mastro et al.
LANCET ONCOLOGY (2021)
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer
Ivica Ratosa et al.
CANCERS (2021)
Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Christopher Jepson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test
Yasutaka Takeda et al.
BMC ENDOCRINE DISORDERS (2019)
Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype
Daniel T. Dibaba et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Anticancer activity of 1,25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway
Wei Zheng et al.
ONCOTARGETS AND THERAPY (2019)
25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects
Giovanni De Pergola et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2019)
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
Sabino De Placido et al.
LANCET ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer
Benedetta Conte et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women
Geoffrey C. Kabat et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention
Manuel Picon-Ruiz et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Neil M. Iyengar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Statins and breast cancer stage and mortality in the Women's Health Initiative
Pinkal Desai et al.
CANCER CAUSES & CONTROL (2015)
Obesity and vitamin D deficiency: a systematic review and meta-analysis
M. Pereira-Santos et al.
OBESITY REVIEWS (2015)
Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
Patrizia Ferroni et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective
Elisa V. Bandera et al.
ADVANCES IN NUTRITION (2015)
Biological subtypes of breast cancer: Prognostic and therapeutic implications
Ozlem Yersal et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
M. Gnant et al.
BRITISH JOURNAL OF CANCER (2013)
Minireview: Obesity and Breast Cancer: A Tale of Inflammation and Dysregulated Metabolism
Evan R. Simpson et al.
MOLECULAR ENDOCRINOLOGY (2013)
Decreasing 25-hydroxy-vitamin D levels account for portion of the effect of increasing body mass index on breast cancer mortality
Matthew L. Morton et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
Saroj Niraula et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer
Joseph A. Sparano et al.
CANCER (2012)
The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications
C. P. Earthman et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer
Aruna V. Krishnan et al.
STEROIDS (2012)
Vitamin D in combination cancer treatment
Yingyu Ma et al.
Journal of Cancer (2012)
Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer
Pankaj G. Vashi et al.
NUTRITION JOURNAL (2011)
Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo
Srilatha Swami et al.
Hormones & Cancer (2011)
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
Alina Vrieling et al.
BREAST CANCER RESEARCH (2011)
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Melinda Protani et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
Ivana Sestak et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study
E. M. Stein et al.
CLINICAL ENDOCRINOLOGY (2009)
Vitamin D in Overweight/Obese Women and Its Relationship With Dietetic and Anthropometric Variables
Elena Rodriguez-Rodriguez et al.
OBESITY (2009)
Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity
Anne-Thea McGill et al.
NUTRITION JOURNAL (2008)
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
Gillian K. Reeves et al.
BRITISH MEDICAL JOURNAL (2007)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Drug therapy: Aromatase inhibitors in breast cancer
IE Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
